MedTrace Logo

Renal Effects of Melatonin Trial in Chronic Kidney Disease

NCT04336566 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-08-03

No results posted yet for this study

Summary

This will be a prospective, double blinded, randomized, controlled pilot study to determine if there is any correlation between melatonin administration and proteinuria.

Conditions

  • Chronic Kidney Diseases

Interventions

DIETARY_SUPPLEMENT

Melatonin

Melatonin 5mg

DIETARY_SUPPLEMENT

Placebo

Comparable Good Neighbor Pharmacy placebo tablet

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Krishna M Baradhi, MD · OUHSC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-05-13
Completion
2020-05-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336566 on ClinicalTrials.gov